Ester-C Plus 1000 mg Vitamin C

Ester-C Plus 1000 mg Vitamin C

Solgar4.9 (18 ratings)
Format:Tablet Quantity: 60 Tablet(s) · 60 servings
$8.83 $0.14 per serving

About this product

Ester-C calcium ascorbate supplies 1,000 mg vitamin C with 100 mg calcium. The buffered format suits people seeking high-dose vitamin C with less acidity than plain ascorbic acid.

Citrus bioflavonoids contribute 200 mg and meaningfully complement the vitamin C core. Acerola, rose hips, and rutin are only 25 mg each and lack potency or standardization details.

One tablet per serving and a low cost make the formula practical. The product should be chosen for buffered vitamin C, not for its small acerola contribution.

Who is it for
  • Adults seeking high-dose Ester-C
  • People sensitive to acidic vitamin C
  • Value-focused daily users
Best for
  • Buffered vitamin C supplementation
  • One-tablet daily use
  • Vitamin C with citrus bioflavonoids

Pros

  • Provides 1,000 mg Ester-C vitamin C
  • Includes 200 mg citrus bioflavonoids
  • Convenient one-tablet serving
  • Low serving cost

Cons

  • Acerola is only 25 mg
  • Rose hips and rutin are lightly dosed
  • Acerola vitamin C yield is unknown
  • Supporting ingredient potency details are absent

Warnings

  • A 1,000 mg vitamin C serving may cause stomach upset or diarrhea
  • High vitamin C intake may not suit people prone to oxalate kidney stones
  • The tablet may be large for people who struggle with swallowing

Product analysis

77 out of 100
High-dose buffered vitamin C and bioflavonoids offer good value. Acerola, rose hips, and rutin are present only in token amounts.

AI assessment of the formula, label and price. How scoring works

Nutrient quality81

Ester-C calcium ascorbate is a well-characterized buffered form, while acerola and rose hips lack potency details. Vitamin C is substantial, but acerola and rutin are too small for focused support.

Ingredient transparency81

Every listed active ingredient has an individual amount. Excipients and daily directions are absent from the supplied data, which leaves some label details uncertain.

Customer satisfaction62

The aggregate satisfaction average is exceptionally strong, though no detailed feedback is supplied. The small volume limits confidence in the aggregate satisfaction signal.

Value for money83

A strong buffered vitamin C dose supports good formula quality despite token botanical additions. The serving offers excellent cost efficiency for the core vitamin C amount.

Format
Tablet
Container
60 Tablet(s)
Per serving
$0.14
Customer rating
4.9 · 18 ratings
Report analysis

Ingredients

IngredientAmount per servingScore
Calories
5 Calorie(s)
Total Carbohydrates
1 Gram(s)
Vitamin C (Ester-C Calcium Ascorbate)
1000 mg
Calcium (Ester-C Calcium Ascorbate)
100 mg
Citrus Bioflavonoid Complex
200 mg
Acerola extract
25 mg 20
Rose Hips
25 mg
Rutin
25 mg
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Sugar Free Halal Vegetarian
Report overview
Acerola · 25 mg OverallScore20
F Composition And Label DisclosureF Composition And Label Disclosure
The Acerola entry in this product lists 25 mg, but the saved information leaves its plant form unknown. It gives no extract ratio or vitamin C contribution and doesn't identify a Latin species or fruit part. The amount is available; the botanical details are not.
How this ingredient is rated

Composition and Label Disclosure20

The Acerola form is recorded as unknown, with no extract ratio or vitamin C contribution listed.
Marker and Preparation Disclosure
The available information gives no extract ratio, vitamin C percentage, or vitamin C yield for the Acerola source.

Composition and Label Disclosure20

An amount is stated, but the botanical identity is incomplete: the Latin species and fruit part are not given.
Acerola Botanical Identity Disclosure
The information lists 25 mg but does not identify the Acerola species or whether the source is fruit, berry, or juice.

Commercial Price and Usability

No price or usability rule applies to this ingredient entry, so no comparison is available here.
Loading alternative details
Report alternatives